[Report of 276 Pages] By the end of 2022, the market for competent cells is anticipated to reach US$ 2.1 billion, growing at a double-digit rate of 11.1% CAGR (2022-2032). By 2032, the market’s sales are projected to be worth $5.9 billion USD. Chemically competent cells held the market’s top spot in terms of product …
Author Archives: Editor AN
Soft Tissue Repair Market projected to reach a valuation of ~US$ 11.66 Billion by 2032
A new report by Future Market Insights (FMI) anticipates the global soft tissue repair market to exhibit a steady 5.5% CAGR throughout the forecast period (2017-2022). The global market for soft tissue repair is expected to account for over US$ 15,000 Mn revenues by 2022-end. Advancements in Products such as Bioabsorbable Soft Tissue Screws to Propel Growth …
Bioabsorbable Stents Market surpassing ~US$ 248.5 Million in 2032
[Report of 250 Pages] The market for bioabsorbable stents was valued at US$ 159.6 million in 2021 and is anticipated to reach US$ 165.4 million by the end of 2022. The market’s sales are anticipated to grow at a CAGR of 4.2% and surpass US$ 248.5 Mn in 2032. According to a recent study, the …
Continue reading “Bioabsorbable Stents Market surpassing ~US$ 248.5 Million in 2032”
Spinal Cord Stimulators Market is expected to grow at over a CAGR of 7.5% during the forecast period 2022 to 2032
[314 Pages Report] According to a recent study by Future Market Insights (FMI), the global dry eye syndrome market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 4.52 Bn in 2021 to around US$ 8.84 Bn by 2031. This reflects a cumulative CAGR of around 7.0% over the forecast period (2022-2031). Dry eye syndrome …
Hidradenitis Suppurative (HS) Treatment Market is projected to reach US$ 1,240.9 million by 2033
The global hidradenitis suppurativa (HS) treatment market is expected to surpass an impressive valuation of US$ 763.6 million in 2023 and is projected to reach US$ 1,240.9 million by 2033, growing at a CAGR of 4.97%. Hidradenitis suppurativa market is currently having vast pipeline therapies targeting interleukins, including (i.e., IL-17, IL-1), anti-TNF, JAKi, and anti-complement factor. The …
Cardiovascular Ultrasound Market is expected to reach a US$ 2.6 billion valuation by 2033
The Cardiovascular Ultrasound market revenues were estimated at US$ 1.2 Billion in 2021 and is anticipated to grow at a CAGR of 7.2% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 2.6 Billion. The market is predicted to grow as preventative medicine becomes more widely used and …
Takotsubo Syndrome Therapeutics Market is projected to exhibit a compound annual growth rate (CAGR) of 6.1% from 2023 to 2033
The global takotsubo syndrome therapeutics market is predicted to exceed an impressive valuation of US$ 2.85 Billion in 2033, with a compound annual growth rate (CAGR) of 6.1% estimated from 2023 to 2033. In both industrialized and developing economies, cardiovascular diseases are the leading cause of death. The rising prevalence of cardiovascular problems such as valvular heart …
Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023
The global Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of6% in the forecast period 2023-2033. The market for Congenital Hyperinsulinism registered a CAGR of 4% in the historical period 2017-2022. The increasing prevalence of Congenital Hyperinsulinism disease is …
Cannabis Use Disorder Treatment Market to reach US$ 2.66 billion by 2033
According to a recent report published by Future Market Insights, demand for cannabis use disorder treatment is poised to grow at a CAGR of 4.9% from 2023 to 2033. By the end of the aforementioned period of assessment, a valuation worth US$ 2.66 billion is anticipated. Today’s global cannabis market is measured in billions of dollars, which …
Continue reading “Cannabis Use Disorder Treatment Market to reach US$ 2.66 billion by 2033”
Chloangiocarcinoma (CCA) Therapeutics Market is expected to garner a market value of US$ 800 Million in 2023
The global Chloangiocarcinoma Therapeutics Market is anticipated to reach a market value of US$ 800 Million in 2023 and US$ 975.20 Million by registering a CAGR of 2% from 2023 to 2033. Inflammatory bowel disease, exposure to specific toxins, and changes in bile duct anatomy are all factors contributing to the growth of the cholangiocarcinoma …